ESC Professional Premium Access

Antithrombotic therapy in TAVI patients without indication for oral anticoagulation.

Congress Presentation

About the speaker

Professor George Dangas

Mount Sinai Medical Center, New York (United States of America)
12 presentations
0 follower

4 more presentations in this session

Embolic stroke. Ischaemic and bleeding risk in patients undergoing TAVI.

Speaker: Professor D. Capodanno (Catania, IT)

Thumbnail

Antithrombotic therapy in TAVI patients with indication for oral anticoagulation.

Speaker: Professor M. Valgimigli (Lugano, CH)

Thumbnail

Antithrombotic therapy during TAVI and peri-interventional management of antithrombotic therapy.

Speaker: Doctor M. Joner (Munich, DE)

Thumbnail

What you need to know about antithrombotic therapy in patients after TAVI – discussion.

Thumbnail

Access the full session

What you need to know about antithrombotic therapy in patients after TAVI

Speakers: Professor G. Dangas, Professor D. Capodanno, Professor M. Valgimigli, Doctor M. Joner
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk